VRX Valeant Pharmaceuticals

Discussion in 'Stocks' started by Hemant Verma, Oct 8, 2016.

  1. I hate Valeant, the company is a pure evil.
     
    #31     Nov 15, 2016
  2. Palindrome

    Palindrome

    I think it already bottomed. I've got a Limit order in at 13.76 to Buy.

    I've got a feeling I might never get filled unfortunately.
     
    #32     Nov 15, 2016
  3. Where does that magic number come from? Current price is 18¼.
     
    #33     Nov 15, 2016
  4. Palindrome

    Palindrome

    its the 52 week low... 4 days ago.... You got a very short memory for a guy named Deuteronomy?

    I am hoping gets retested for me to buy. I don't think it will happen though. I think it bottomed already. But I am waiting patiently to hit that entrance. If 3 weeks from now it is trading at 25, I will have to move to the next stock and forget this piece of garbage trading vehicle.

    As I mentioned a couple weeks back, I think this will bottom between 9 and 16.
     
    #34     Nov 15, 2016
  5. So you can "make" $4½ by buying it cheaper than its current price, but are willing to "lose" $100 (or whatever) if it skyrockets without you on board?
     
    #35     Nov 15, 2016
  6. Palindrome

    Palindrome

    My model says it has not bottomed yet. My model is wrong at times. But if I stray from my model then I would just be gambling.

    I'm about 9 for 10 on market calls on this website, so I trust my model.
     
    #36     Nov 15, 2016
    Deuteronomy_24_7 likes this.
  7. Jamie J.

    Jamie J.

    I think this is not that stock where people should spend their money. It is not stable in recent time.
     
    #37     Nov 15, 2016
    DallasCowboysFan likes this.
  8. Hope they will go belly up soon enough.
     
    #38     Nov 16, 2016
  9. Jamie J.

    Jamie J.

    Sorry, but hopes are unlikely to help. VRX is too risky and may turn into a real problem.
     
    #39     Nov 16, 2016
  10. Hope folks are paying attention to institutional buying this up like pot in Colorado
     
    #40     Nov 17, 2016
    Albert A. Sanchez likes this.